Earnings History Data for Adverum Biotechnologies (ADVM) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Adverum Biotechnologies
Adverum is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. Adverum develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Adverum?s core capabilities include clinical development, novel vector discovery and in-house manufacturing expertise, specifically in scalable process development, assay development, and current Good Manufacturing Practices quality control.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 04-11-2024 | AH | ADVM | Adverum Biotechnologies | 152.00 | -1.30 | -1.20 | 0.00 | Adverum Biotechnologies GAAP EPS of -$1.30 beats by $0.01 [11/4/2024 5:27 PM] |
7.71 | 0.17 (2.25%) |
7.54 | 0.0 (0.00%) |
6.38 - 29.70 | 87,044 | 150,000 | 5,722 | ||
|
||||||||||||||||||
| 12-08-2024 | AH | ADVM | Adverum Biotechnologies | 144.00 | -0.89 | -1.27 | 0.00 | Adverum Biotechnologies GAAP EPS of -$0.89 beats by $0.58 [8/12/2024 4:47 PM] |
6.72 | 0.23 (3.54%) |
6.62 | 0.13 (2.00%) |
6.38 - 29.70 | 130,071 | 220,000 | 2,612 | ||
| 18-03-2024 | AH | ADVM | Adverum Biotechnologies | 358.00 | -0.23 | -0.28 | 0.00 | Adverum Biotechnologies GAAP EPS of -$0.23 beats by $0.11 [3/18/2024 4:35 PM] |
1.63 | -0.14 (-7.91%) |
1.68 | -0.09 (-5.08%) |
0.68 - 2.97 | 3,265,218 | 2,000,000 | 11,032 | ||
| 30-03-2023 | PM | ADVM | Adverum Biotechnologies | 80.00 | -0.33 | -0.32 | 0.00 | Adverum Biotechnologies GAAP EPS of -$0.33 beats by $0.03 [3/31/2023 12:36 AM] |
0.7199 | 0.0 (-0.01%) |
0.77 | 0.05 (6.94%) |
0.53 - 1.82 | 90,847 | 720,000 | 2,066 | ||
| 29-03-2022 | AH | 4:05 PM ET (Mar 29) |
ADVM | Adverum Biotechnologies, Inc. | 137.41 | -0.35 | -0.42 | -0.39 | Adverum Biotechnologies GAAP EPS of -$0.35 misses by $0.01 [3/29/2022 4:49 PM] |
1.34 | -0.04 (-3.24%) |
1.39 | 0.0 (0.00%) |
1.21 - 10.85 | 526,035 | 2,010,000 | 1,400 | |
| 05-08-2021 | AH | 4:00 PM ET (Aug 5) |
ADVM | Adverum Biotechnologies, Inc. | 231.00 | -0.45 | -0.37 | 0.00 | Adverum Biotechnologies EPS misses by $0.07 [8/5/2021 5:25 PM] |
2.48 | 0.07 (2.90%) |
2.36 | -0.05 (-2.07%) |
2.23 - 19.25 | 1,908,386 | 3,170,000 | 25,225 | |
| 01-03-2021 | AH | 4:00 PM ET (Mar 1) |
ADVM | Adverum Biotechnologies, Inc. | 1,250 | -0.39 | -0.32 | -0.29 | Adverum Biotechnologies EPS misses by $0.06 [3/1/2021 4:06 PM] |
12.29 | -1.03 (-7.73%) |
13.25 | -0.07 (-0.53%) |
7.36 - 26.98 | 547,251 | 749,925 | 1,028 | |
| 05-11-2020 | AH | ADVM | Adverum Biotechnologies, Inc. | 1,180 | -0.31 | -0.35 | -0.25 | Adverum Biotechnologies EPS beats by $0.04, beats on revenue [11/5/2020 5:18 PM] |
12.05 | -0.13 (-1.07%) |
12.18 | 0.0 (0.00%) |
7.15 - 26.98 | 497,691 | 837,892 | 100 | ||
|
|
||||||||||||||||||
| 10-08-2020 | AH | 4:00 PM ET (Aug 10) |
ADVM | Adverum Biotechnologies, Inc. | 1,430 | -0.36 | -0.30 | -0.23 | Adverum Biotechnologies EPS misses by $0.06, beats on revenue [8/10/2020 4:09 PM] |
16.75 | -1.95 (-10.43%) |
19.00 | 0.30 (1.60%) |
4.96 - 26.98 | 991,114 | 702,921 | 2,028 | |
|
|
||||||||||||||||||
| 28-05-2020 | AH | 4:00 PM ET (May 28) |
ADVM | Adverum Biotechnologies, Inc. | 1,640 | -0.31 | -0.27 | -0.23 | Adverum Biotechnologies EPS misses by $0.04 [5/28/2020 4:11 PM] |
17.97 | -2.35 (-11.56%) |
19.88 | -0.44 (-2.17%) |
4.96 - 23.79 | 868,899 | 934,250 | 379 | |
|
|
||||||||||||||||||